Advanced Oxygen Therapy
Oceanside · Founded 2004
About Advanced Oxygen Therapy
Advanced Oxygen Therapy is dedicated to providing Advanced Wound Care products that utilize our patented non-invasive Topical Wound Oxygen (TWO2) therapy. Our innovative products can help close all wound types, and are particularly effective in chronic (diabetic, pressure, and venous ulcers) and acute (post-surgical, cosmetic, and burn) wounds. TWO2 therapy is unique in that it helps to address the fundamental reasons chronic wounds fail to heal by; reversing wound tissue hypoxia, stimulating the underlying cellular mechanisms needed for tissue regeneration, creating non-contact sequential compression to reduce edema and promote perfusion, and creating an environment that destroys unwanted pathogens and combats infection. In closing previously unresponsive wounds, TWO2 therapy has significant impact on saving limbs, reducing overall healthcare costs, and greatly improving patients’ quality of life.
Company Facts
- Founded: 2004
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Funding stage: IPO
- Last round: Corporate Round (Mar 2022)
- Ticker: lse:AOTI
- Website: http://aotinc.net/
- Phone: 7606833063
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/advanced-oxygen-therapy-107650 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.